These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 19765233
1. Assessment of resynchronization therapy on functional status and quality of life in patients requiring an implantable defibrillator. Pinter A, Mangat I, Korley V, Connolly S, Connors S, Gardner M, Philippon F, Sterns L, Thibault B, Dorian P. Pacing Clin Electrophysiol; 2009 Dec; 32(12):1509-19. PubMed ID: 19765233 [Abstract] [Full Text] [Related]
2. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR. J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [Abstract] [Full Text] [Related]
3. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Boriani G, Müller CP, Seidl KH, Grove R, Vogt J, Danschel W, Schuchert A, Djiane P, Biffi M, Becker T, Bailleul C, Trappe HJ, Resynchronization for the HemodYnamic Treatment for Heart Failure Management II Investigators. Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335 [Abstract] [Full Text] [Related]
4. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Belardinelli R, Capestro F, Misiani A, Scipione P, Georgiou D. Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224 [Abstract] [Full Text] [Related]
5. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group. Circulation; 2004 Nov 02; 110(18):2864-8. PubMed ID: 15505095 [Abstract] [Full Text] [Related]
6. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. Beshai JF, Grimm RA, Nagueh SF, Baker JH, Beau SL, Greenberg SM, Pires LA, Tchou PJ, RethinQ Study Investigators. N Engl J Med; 2007 Dec 13; 357(24):2461-71. PubMed ID: 17986493 [Abstract] [Full Text] [Related]
7. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure. Davis DR, Krahn AD, Tang AS, Lemery R, Green MS, Gollob M, Yee R, Skanes AC, Klein GJ, Birnie DH. Can J Cardiol; 2005 Apr 13; 21(5):413-7. PubMed ID: 15861258 [Abstract] [Full Text] [Related]
8. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group. J Am Coll Cardiol; 2009 Nov 10; 54(20):1837-46. PubMed ID: 19800193 [Abstract] [Full Text] [Related]
9. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. Steendijk P, Tulner SA, Bax JJ, Oemrawsingh PV, Bleeker GB, van Erven L, Putter H, Verwey HF, van der Wall EE, Schalij MJ. Circulation; 2006 Mar 14; 113(10):1295-304. PubMed ID: 16520415 [Abstract] [Full Text] [Related]
10. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience. Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB. J Med Assoc Thai; 2007 Jul 14; 90(7):1458-66. PubMed ID: 17710992 [Abstract] [Full Text] [Related]
11. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ. Am J Cardiol; 2007 Dec 01; 100(11):1665-70. PubMed ID: 18036366 [Abstract] [Full Text] [Related]
12. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS. Am J Cardiol; 2007 Jul 01; 100(1):90-3. PubMed ID: 17599447 [Abstract] [Full Text] [Related]
13. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator. Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY. Europace; 2009 Jan 01; 11(1):80-5. PubMed ID: 18952828 [Abstract] [Full Text] [Related]
14. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure. Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A. Ital Heart J; 2004 May 01; 5(5):364-70. PubMed ID: 15185900 [Abstract] [Full Text] [Related]
15. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS? Gasparini M, Regoli F, Galimberti P, Ceriotti C, Bonadies M, Mangiavacchi M, Andreuzzi B, Bragato R, Pini D, Klersy C, Gronda E. Pacing Clin Electrophysiol; 2007 Jan 01; 30 Suppl 1():S34-9. PubMed ID: 17302713 [Abstract] [Full Text] [Related]
16. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Circulation; 2006 Dec 19; 114(25):2766-72. PubMed ID: 17159063 [Abstract] [Full Text] [Related]
17. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. JAMA; 2003 May 28; 289(20):2685-94. PubMed ID: 12771115 [Abstract] [Full Text] [Related]
18. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Gold MR, Daubert JC, Abraham WT, Hassager C, Dinerman JL, Hudnall JH, Cerkvenik J, Linde C. Circ Arrhythm Electrophysiol; 2013 Dec 28; 6(6):1163-8. PubMed ID: 24125796 [Abstract] [Full Text] [Related]
19. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Foley PW, Muhyaldeen SA, Chalil S, Smith RE, Sanderson JE, Leyva F. Europace; 2009 Apr 28; 11(4):495-501. PubMed ID: 19307283 [Abstract] [Full Text] [Related]
20. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up. Faran A, Lewicka-Nowak E, Dabrowska-Kugacka A, Kempa M, Tybura S, Szwoch M, Królak T, Raczak G. Kardiol Pol; 2008 Jan 28; 66(1):19-26; discussion 27. PubMed ID: 18266184 [Abstract] [Full Text] [Related] Page: [Next] [New Search]